Abiraterone Acetate Soft Capsules(Jiangsu Wangao Pharma)

醋酸阿比特龙软胶囊(江苏万高药业)

Report date: 2025/09/23 11:24:22

Base Information

Drug NameAbiraterone Acetate Soft Capsules(Jiangsu Wangao Pharma)
Drug Alias NameAbiraterona乙酸阿比特龙酯Abiraterone acetate fine particle阿比特隆Abirateronum +[13
ClassificationSmall molecules > SteroidsSmall molecules > Prodrug
Mechanisms of ActionSteroid 17-alpha-hydroxylase inhibitors
TargetsSteroid 17-alpha-hydroxylase
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A